Long-Term Effectiveness of Liraglutide for Weight Management and Glycemic Control in Type 2 Diabetes
出版年份 2019 全文链接
标题
Long-Term Effectiveness of Liraglutide for Weight Management and Glycemic Control in Type 2 Diabetes
作者
关键词
-
出版物
International Journal of Environmental Research and Public Health
Volume 17, Issue 1, Pages 207
出版商
MDPI AG
发表日期
2019-12-28
DOI
10.3390/ijerph17010207
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Quantifying Importance of Major Risk Factors for Coronary Heart Disease
- (2019) Michael J. Pencina et al. CIRCULATION
- The transferability of lipid loci across African, Asian and European cohorts
- (2019) Karoline Kuchenbaecker et al. Nature Communications
- Long-Term Effectiveness and Safety of SGLT-2 Inhibitors in an Italian Cohort of Patients with Type 2 Diabetes Mellitus
- (2019) Maria Mirabelli et al. Journal of Diabetes Research
- Cardiovascular disease risk prediction models: challenges and perspectives
- (2019) Farshad Farzadfar Lancet Global Health
- Differential lipid metabolism outcomes associated with ADRB2 gene polymorphisms in response to two dietary interventions in overweight/obese subjects
- (2018) O. Ramos-Lopez et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Clinical Impact of 5 Years of Liraglutide Treatment on Cardiovascular Risk Factors in Patients with Type 2 Diabetes Mellitus in a Real-Life Setting in Italy: An Observational Study
- (2018) Vera Frison et al. Diabetes Therapy
- 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2019
- (2018) DIABETES CARE
- Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2018) Melanie J. Davies et al. DIABETES CARE
- Cardiovascular risk assessment in patients with diabetes
- (2017) Marcello Casaccia Bertoluci et al. Diabetology & Metabolic Syndrome
- Exposure-response analyses of liraglutide 3.0 mg for weight management
- (2016) J. P. H. Wilding et al. DIABETES OBESITY & METABOLISM
- Clinical Effectiveness of Liraglutide in Type 2 Diabetes Treatment in the Real-World Setting: A Systematic Literature Review
- (2016) Amrita Ostawal et al. Diabetes Therapy
- Clinical Effectiveness of Liraglutide in Type 2 Diabetes Treatment in the Real-World Setting: A Systematic Literature Review
- (2016) Amrita Ostawal et al. Diabetes Therapy
- A polymorphism of HMGA1 protects against proliferative diabetic retinopathy by impairing HMGA1-induced VEGFA expression
- (2016) Eusebio Chiefari et al. Scientific Reports
- Liraglutide reduces the body weight and waist circumference in Chinese overweight and obese type 2 diabetic patients
- (2015) Ping Feng et al. ACTA PHARMACOLOGICA SINICA
- Correlation Between Baseline Characteristics and Clinical Outcomes in a Large Population of Diabetes Patients Treated with Liraglutide in a Real-World Setting in Italy
- (2015) Annunziata Lapolla et al. CLINICAL THERAPEUTICS
- Add-On Treatment with Liraglutide Improves Glycemic Control in Patients with Type 2 Diabetes on Metformin Therapy
- (2015) Eusebio Chiefari et al. Diabetes Technology & Therapeutics
- Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes
- (2015) Melanie J. Davies et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Effect of Glucagon-Like Peptide 1 Receptor Agonists on Weight Loss in Type 2 Diabetes: A Systematic Review and Mixed Treatment Comparison Meta-Analysis
- (2015) Jessica E. Potts et al. PLoS One
- GLP-1 Receptor Activation Modulates Appetite- and Reward-Related Brain Areas in Humans
- (2014) L. van Bloemendaal et al. DIABETES
- The importance of weight management in type 2 diabetes mellitus
- (2014) J. P. H. Wilding INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Sex and gender influences on pharmacological response: an overview
- (2014) Flavia Franconi et al. Expert Review of Clinical Pharmacology
- A polymorphism of HMGA1 is associated with increased risk of metabolic syndrome and related components
- (2013) Eusebio Chiefari et al. Scientific Reports
- Gender difference in response predictors after 1-year exenatide therapy twice daily in type 2 diabetic patients: a real world experience
- (2013) Giuseppe Seghieri et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Medical Therapy for the Patient With Obesity
- (2012) George A. Bray et al. CIRCULATION
- An Overview of the Genetic Structure within the Italian Population from Genome-Wide Data
- (2012) Cornelia Di Gaetano et al. PLoS One
- Sex-Gender Differences in Diabetes Vascular Complications and Treatment
- (2012) Flavia Franconi et al. Endocrine Metabolic & Immune Disorders-Drug Targets
- Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes
- (2011) R. R. Wing et al. DIABETES CARE
- Achieving a clinically relevant composite outcome of an HbA1c of
- (2011) B. Zinman et al. DIABETES OBESITY & METABOLISM
- One-year metabolic outcomes in patients with type 2 diabetes treated with exenatide in routine practice
- (2010) M. Buysschaert et al. DIABETES & METABOLISM
- Switching to Once-Daily Liraglutide From Twice-Daily Exenatide Further Improves Glycemic Control in Patients With Type 2 Diabetes Using Oral Agents
- (2010) J. B. Buse et al. DIABETES CARE
- Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?
- (2010) M. A. Nauck et al. DIABETOLOGIA
- Common Variants of HMGCR, CETP, APOAI, ABCB1, CYP3A4, and CYP7A1 Genes as Predictors of Lipid-Lowering Response to Atorvastatin Therapy
- (2010) Aruna Poduri et al. DNA AND CELL BIOLOGY
- Biological, clinical and population relevance of 95 loci for blood lipids
- (2010) Tanya M. Teslovich et al. NATURE
- Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)
- (2009) B. Zinman et al. DIABETES CARE
- Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)
- (2009) M. Marre et al. DIABETIC MEDICINE
- Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial
- (2009) D. Russell-Jones et al. DIABETOLOGIA
- Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
- (2009) John B Buse et al. LANCET
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started